Development research program

  • Description
  • Details
  • Subprojects
  • History
  • Publications
  • Patents
  • Trials
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
 
Project Description:
The developmental funds portion of our SPORE has proven to be one of the most vital aspects of our translational work in lung cancer. As will be detailed below, over the duration of the SPORE, several of our most productive full projects began as pilot projects funded through this Developmental Program. Also, this program has made possible the initiation of academic careers for multiple translational investigators who are now key players in this and other SPORES. It has also brought basic investigators to lung cancer research who might not have ever worked on these diseases. Finally, as will be evident below in the full presentation of three planned projects for the current proposal, we have used the Developmental Program mechanism to bring innovative new concepts and technology into the SPORE to foster our highest translational aims.
 
Project Terms:
adenocarcinoma adjuvant adverse event aerosols animals anticancer research aqueous award azacitidine biological markers blood caliber cancer patient cancer therapy canis familiaris career characteristics data demethylation deposition development disease drug formulations drug kinetics early diagnosis efficacy testing event fostering foundations funding gene silencing generations genes half-life head histone deacetylase inhibitor human hypermethylation innovation insight knowledge laboratories liquid substance lung lymph nodes malignant neoplasm of lung methylation myeloproliferative disease nanoparticle nanopolymer nebulizer new mexico nonhuman primate particle size pathway interactions patients pharmaceutical preparations pharmacologic substance phase i clinical trials phase i/ii trial pilot projects programs promoter property recurrence research and development research institute research personnel resected respiratory rodent route signal pathway sputum squamous cell carcinoma staging structure of parenchyma of lung subcutaneous injections technology testing therapeutic agents time toxicology translating tumor tumor suppressor genes united states national institutes of health universities work bioengineering cancer clinical research clinical trials genetics hiv/aids lung cancer nanotechnology prevention
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
Organization: Johns Hopkins University, United States, Maryland, BALTIMORE
Principal Investigators (PI): Baylin Stephen B, US
 
Project Categories:
Natural Sciences > Aging Diseases and Pathology > Cancer & related diseases > Malignant neoplasms (including in situ)
 
Other Information:
Fiscal Year: 2011
Project Start Date: 1 December 2011
Project End Date: 30 November 2012
Project program: Specialized Center
 
Project Funding Information:
Funding Mechanism: Research Centers
Year Funding Organization Total Funding, $
2012 NIH - National Cancer Institute $247,025
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
 
Title FY Funding
There are no results for this project in database.
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
 
Title Journal Year Country Rel
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
 
Title Year
Project Title: Development research program
Project Number: 5P50CA058184-17-8054
Project web address: Follow on NIH
Parent Project: 5P50CA058184-17
 
Title Phase Year